Table 2.

Comparison of Treatment Groups at Baseline in the ITT population

Baseline Characteristics		IFX (N=10)	Placebo (N= 10)	P-value [1]
Age (Years)	median (min, max)	52 (21, 63)	54.5 (30, 71)	0.7
Gender		6 male; 4 female	6 male;4 female	1.0
Race		10 white	7 white/3 black	0.2
Initial Prednisone (mg/day)	median (min, max)	22.5 (20, 100)	45 (20, 65)	0.1
PV Disease Activity (0,mild-5,severe)	median (min, max)	3.0 (1, 5)	3.0 (0, 5)	0.9
IgG anti-DSG3 (u/ml)	median (min, max)	248 (0.08, 1595)	820 (77, 27788)	0.09
IgG anti-DSG1 (u/ml)	median (min, max)	92 (0.73, 453)	47 (6.0,669 )	0.9

^[1]P-values are derived from the 2-sided Mann-Whitney test for continuous variables or Fisher’s Exact for categorical variables.